Patients with new-onset AFib at greatest risk for complications after TAVR

Cardiac patients who develop new-onset atrial fibrillation (AFib) after transcatheter aortic valve replacement (TAVR) are at a higher risk for complications like stroke, myocardial infarction and death than those whose AFib was established before the procedure, researchers report in the current online issue of JACC: Cardiovascular Interventions.